International Clinical Trial: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Phase IIa Clinical Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of SIM0278 in Subjects with Active Lupus Nephritis

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119847) titled 'A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Phase IIa Clinical Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of SIM0278 in Subjects with Active Lupus Nephritis' on March 4.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Peking Union Medical College Hospital

Condition: Systemic lupus erythematosus

Intervention: SIM0278 300 µg Q2W placebo group:SIM0278 300 µg Q2W placebo

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-03-20

Target Sample Size: SIM0278 300 µg Q2W placebo group:30;SIM0278 ...